Detalhe da pesquisa
1.
Capsid Inhibition with Lenacapavir in Multidrug-Resistant HIV-1 Infection.
N Engl J Med
; 386(19): 1793-1803, 2022 05 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-35544387
2.
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat.
Clin Gastroenterol Hepatol
; 21(1): 143-152.e3, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34999207
3.
Combination Therapies Including Cilofexor and Firsocostat for Bridging Fibrosis and Cirrhosis Attributable to NASH.
Hepatology
; 73(2): 625-643, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33169409
4.
Trophectoderm differentiation to invasive syncytiotrophoblast is promoted by endometrial epithelial cells during human embryo implantation.
Hum Reprod
; 37(4): 777-792, 2022 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35079788
5.
Emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial.
Lancet
; 396(10246): 239-254, 2020 07 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-32711800
6.
Glecaprevir-Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection.
N Engl J Med
; 378(4): 354-369, 2018 01 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29365309
7.
Long-term Benefits of Sustained Virologic Response for Patient-Reported Outcomes in Patients With Chronic Hepatitis C Virus Infection.
Clin Gastroenterol Hepatol
; 18(2): 468-476.e11, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31376493
8.
Embryo-epithelium interactions during implantation at a glance.
J Cell Sci
; 130(1): 15-22, 2017 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28043966
9.
GS-0976 Reduces Hepatic Steatosis and Fibrosis Markers in Patients With Nonalcoholic Fatty Liver Disease.
Gastroenterology
; 155(5): 1463-1473.e6, 2018 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-30059671
10.
Sofosbuvir/Velpatasvir/Voxilaprevir for patients with HCV who previously received a Sofosbuvir/Velpatasvir-containing regimen: Results from a retreatment study.
J Viral Hepat
; 26(6): 770-773, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30663168
11.
Glecaprevir/Pibrentasvir in patients with chronic HCV genotype 3 infection: An integrated phase 2/3 analysis.
J Viral Hepat
; 26(3): 337-349, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30421537
12.
Efficacy and Safety of Glecaprevir/Pibrentasvir in Patients Coinfected With Hepatitis C Virus and Human Immunodeficiency Virus Type 1: The EXPEDITION-2 Study.
Clin Infect Dis
; 67(7): 1010-1017, 2018 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-29566246
13.
Sofosbuvir and Velpatasvir for HCV Genotype 1, 2, 4, 5, and 6 Infection.
N Engl J Med
; 373(27): 2599-607, 2015 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26571066
14.
Daclatasvir plus Sofosbuvir for HCV in Patients Coinfected with HIV-1.
N Engl J Med
; 373(8): 714-25, 2015 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26196502
15.
Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1.
N Engl J Med
; 373(8): 705-13, 2015 Aug 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-26196665
16.
Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection.
N Engl J Med
; 373(27): 2608-17, 2015 Dec 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-26575258
17.
Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials.
Gastroenterology
; 153(1): 113-122, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28390869
18.
Osmotic stress induces JNK-dependent embryo invasion in a model of implantation.
Reproduction
; 156(5): 421-428, 2018 10 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-30131400
19.
TURQUOISE-I Part 1b: Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir with Ribavirin for Hepatitis C Virus Infection in HIV-1 Coinfected Patients on Darunavir.
J Infect Dis
; 215(4): 599-605, 2017 02 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-28329334
20.
Sofosbuvir and Velpatasvir for the Treatment of Hepatitis C Virus in Patients Coinfected With Human Immunodeficiency Virus Type 1: An Open-Label, Phase 3 Study.
Clin Infect Dis
; 65(1): 6-12, 2017 Jul 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28369210